Skip to main content
. Author manuscript; available in PMC: 2014 May 15.
Published in final edited form as: Cochrane Database Syst Rev. 2013 Oct 23;10:CD001055. doi: 10.1002/14651858.CD001055.pub4
Methods Cluster-randomised controlled trial to test the effectiveness of the ALA smoking in pregnancy intervention to support women to stop smoking in pregnancy
Study conducted in 11 private obstetric practices in Michigan and Upper Wisconsin (USA), with recruitment from August 1985 to June 1986
Participants Inclusion criteria: 24 physicians in 11 private practices participated in the study (12 family physicians and 12 obstetricians). Study practices randomised into ‘roughly equal groups’. Women smoking at first antenatal appointment, less than 28 weeks’ gestation were recruited to study
Exclusion criteria: Not further specified.
Recruitment: All women attending those clinics invited to participate. After giving informed consent, each woman was assigned a code number and had a questionnaire pack placed in her chart. 639 women screened (5 refusals), 206 smokers (32%), 69/209 had quit since becoming pregnant and 137 continuing smokers were included in the study (C = 70, I = 67)
Baseline characteristics: Pre-pregnancy mean cigs per day = 20; current mean cigarettes per day = 11
98% white, 70% married, majority (80%) completed high school
Progress+ coding: None.
Interventions Control: 3 counselling sessions with physician on risks, ashtrays removed from waiting rooms and staff asked not to smoke in front of patients
Intervention: Control plus (i) use of ALA materials (because you love your baby flip chart; because you love your baby packets, because you love your baby poster) (ii) encouragement to send off for materials (freedom from smoking manual), (iii) slide tape presentation at each women’s first obstetrics visit
Main intervention strategy: Counselling (multiple intervention) compared to less intensive intervention
Intensity: Frequency (C = 3, I = 5), Duration (C = 1, I = 2).
Intervention provided by existing staff (physicians): Effectiveness study
Outcomes Self-reported smoking abstinence at 32-36 weeks’ gestation (late pregnancy*) and first postpartum visit (timing not specified but assumed is standard 6 weeks pp visit), 0-5 months pp*
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection bias) Low risk Stratified by size - and then assigned by coin toss.
Allocation concealment (selection bias) High risk Allocation not concealed with coin toss randomisation.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 7 miscarriages (C = 4, I = 3), 2 therapeutic abortions (C = 0, I = 2), 11 moved (C = 6, I = 5) and 8 had an incomplete dataset (C = 4, I = 4). Those with incomplete dataset were re-included as continuing smokers in this review (C = 60, I = 57)
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking abstinence (detection bias) High risk No biochemical validation of smoking status (self-report only)
Blinding of participants and personnel (performance bias)
All outcomes
High risk Not feasible to blind providers and women to educational intervention
Blinding of outcome assessment (detection bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Exact rates not reported - but ‘only minor deviations’ suggests very high implementation
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Cluster-randomised by clinic - so unlikely to have ALA materials